Global Hepatitis C Testing Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 733.60 Million |
 Market Size (Forecast Year) |
USD 1,178.10 Million |
 CAGR |
% |
| Major Markets Players |
Global Hepatitis C Testing Market, By Test Kits (Hepatitis C Antibody Test, Hepatitis C RNA Quantitative Test, Hepatitis C RNA Qualitative Test, Hepatitis C RIBA, Hepatitis C Genotype, Viral Load), Technique (Immunoassays, Polymerase Chain Reaction (PCR), Others), End User (Hospital and Clinics, Diagnostic Laboratories, Others) – Industry Trends and Forecast to 2030.
Hepatitis C Testing Market Analysis and Size
The increasing burden of different infectious diseases on the healthcare system is a main consideration, with emerging countries bearing a disproportionate share of the burden. As per the Institute of Liver and Biliary Sciences India, about 3% of the world's population is hugely infected with the hepatitis C virus. The increase in the occurrence of HCV infections particularly both in developed and developing countries is a primary factor leading to the growth of the hepatitis C testing market.
Data Bridge Market Research analyses that the hepatitis C testing market is expected to reach USD 1178.1 million by 2030, which is USD 733.6 million in 2022, and is expected to undergo a CAGR of 6.1% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Hepatitis C Testing Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015 - 2020) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Test Kits (Hepatitis C Antibody Test, Hepatitis C RNA Quantitative Test, Hepatitis C RNA Qualitative Test, Hepatitis C RIBA, Hepatitis C Genotype, Viral Load), Technique (Immunoassays, Polymerase Chain Reaction (PCR), Others), End User (Hospitals, Trauma Centres, Ambulatory Surgical Centres and Other), Distribution Channel (Direct Tender and Retail Sales) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
Abbott (U.S.), Bio-Rad Laboratories Inc. (U.S.), QIAGEN (Germany), Bayer AG (Germany), OraSure Technologies, Inc. (U.S.), Sysmex Corporation (Japan), Meridian Bioscience (U.S.), Biogate Laboratories Ltd. (Canada), J. Mitra & Co. Pvt. Ltd (India), General Biologicals Corporation (Taiwan), BioGenex (China), F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Siemens Healthcare GmbH (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Ortho Clinical Diagnostics (U.S.), Quest Diagnostics Incorporated (U.S.), Abcam Plc (U.K.) |
|
Market Opportunities |
|
Market Definition
Molecular diagnostics that is used in hepatitis testing involve genetic tests to demonstrate the accurate damage of the causative virus. This blood test, called an HCV antibody test, is performed to know if a person has ever been infected with the hepatitis C virus. The HCV antibody test, also called the anti-HCV test, identifies antibodies to the hepatitis C virus in blood.
Hepatitis C Testing Market Dynamics
Drivers
- Increasing Techniques For Screening
Hepatitis C screening is essential before organ donation, and increasing organ donation projects globally are projected to boost the future growth. The introduction of point-of-care testing products for HCV testing increases the potential for HCV testing kits. In 2010, the FDA approved the OraQuick HCV Rapid Antibody Test, which is now extensively used as a substitute for enzyme immunoassay testing for HCV. The wide use of new electrochemical immuno sensor and nano sensor technologies in HPV testing is projected to change current practices. This boosts the market growth.
- Rise in Antibody Test
The antibody test segment contributes to the market growth. This dominance is because of the benefits of antibody tests and advancements in testing the hepatitis C virus. The huge demand for other tests such as genotype tests and viral load tests will surge in the forecast period because of the improvements and test accuracies and adoption by expert professionals.
Opportunities
- Growing Launch of Detection Tests
There ve been detection tests available which boosts the market growth. For instance, NATSpert, established in 2017 in Pune, India, is a developer of blood detection kits for several viral diseases. Its product called NATSpert ID TripleH is a qualitative, real-time PCR test for the simultaneous detection of HIV, HBV and HCV respectively. The kit is available in a single tube format, and allows for screening of HIV-2 RNA, HIV-1 group-O RNA, HIV type 1 group M-RNA, Hepatitis C Virus RNA and Hepatitis B Virus DNA in human blood plasma. HepC is a manufacturer of antiviral biologic products that was founded in 2005. The company deploys IBDV as a non-pathogenic double-stranded RNA virus. It acts as a master activator of antiviral gene responses due to its primary vector system. Its product development includes HC001 for the treatment of advanced chronic viral hepatitis caused by HBV and HCV infections
Restraints/Challenges
- High cost of Diagnostic Tests
There have been different tests that are widely available for testing hepatitis diseases. These tests are of much high cost several patientsseveral patients do not afford do not affordand are not afforded by several patients, particularly those belonging to the lower economic groups. Therefore, it hampers the market growth.
This hepatitis C testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the hepatitis C testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Hepatitis C Testing Market Scope
The hepatitis C testing market is segmented on the basis of test kits, technique and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Test Kits
- Hepatitis C Antibody Test
- Hepatitis C RNA Quantitative Test
- Hepatitis C RNA Qualitative Test
- Hepatitis C RIBA
- Hepatitis C Genotype
- Viral Load
Technique
- Immunoassays
- Polymerase Chain Reaction (PCR)
- Others
End-User
- Hospital and Clinics
- Diagnostic Laboratories
- Others
Hepatitis C Testing Regional Analysis/Insights
The hepatitis C testing market is analyzed and market size insights and trends are provided by test kits, technique and end-user as referenced above.
The countries covered in the hepatitis C testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the hepatitis C testing market because of the growing incidences of cancer with increasing number of diagnostic instruments and laboratories.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 to the increasing disease prevalence rates in the developing and underdeveloped countries in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The hepatitis C testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for hepatitis C testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the hepatitis C testing market. The data is available for historic period 2011-2021.
Competitive Landscape and Global Hepatitis C Testing Market Share Analysis
The hepatitis C testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to hepatitis C testing market.
Some of the major players operating in the hepatitis C testing market are:
- Abbott (U.S.)
- Bio-Rad Laboratories Inc. (U.S.)
- QIAGEN (Germany)
- Bayer AG (Germany)
- OraSure Technologies, Inc. (U.S.)
- Sysmex Corporation (Japan)
- Meridian Bioscience (U.S.)
- Biogate Laboratories Ltd.(Canada)
- J. Mitra & Co. Pvt. Ltd (India)
- General Biologicals Corporation (Taiwan)
- BioGenex (China)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (U.S.)
- Siemens Healthcare GmbH (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Ortho Clinical Diagnostics (U.S.)
- Quest Diagnostics Incorporated (U.S.)
- Abcam Plc (U.K.)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
